Friederike Herbst
7PUBLICATIONS
86CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jan 20, 2025
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies.Julie K Jadlowsky, Elizabeth O Hexner, Amy Marshall
|Nov 13, 2024
TET2 regulates early and late transitions in exhausted CD8+ T cell differentiation and limits CAR T cell function.Alexander J Dimitri, Amy E Baxter, Gregory M Chen
|Aug 31, 2023
Epitope base editing CD45 in hematopoietic cells enables universal blood cancer immune therapy.Nils Wellhausen, Ryan P O'Connell, Stefanie Lesch
|Apr 03, 2023
Type I Interferon Signaling via the EGR2 Transcriptional Regulator Potentiates CAR T Cell-Intrinsic Dysfunction.In-Young Jung, Robert L Bartoszek, Andrew J Rech
|Jul 12, 2021
Response to Cabozantinib Following Acquired Entrectinib Resistance in a Patient With ETV6-NTRK3 Fusion-Positive Carcinoma Harboring the NTRK3 G623R Solvent-Front Mutation.Dorothea Hanf, Christoph Heining, Karin Laaber
|May 22, 2021
The balance between the intronic miR-342 and its host gene Evl determines hematopoietic cell fate decision.Friederike Herbst, Tonio J L Lang, Elias S P Eckert
Pageof 2
Frequent Collaborators
3 joint publications
Joseph A Fraietta
3 joint publications
Karin Laaber
3 joint publications
Frederic D Bushman
2 joint publications
John K Everett
2 joint publications
Naomi B Haas
2 joint publications
Gabriela Plesa
2 joint publications
Caitlin R Hopkins
2 joint publications
Donald L Siegel
2 joint publications
Noelle V Frey
2 joint publications
Robert L Bartoszek
